These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 7207751)

  • 1. 1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced pulmonary fibrosis.
    Selker RG; Jacobs SA; Moore PB; Wald M; Fisher ER; Cohen M; Bellot P
    Neurosurgery; 1980 Dec; 7(6):560-5. PubMed ID: 7207751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary fibrosis: a complication of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) therapy.
    Ryan BR; Walters TR
    Cancer; 1981 Aug; 48(4):909-11. PubMed ID: 7272934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Irreversible pulmonary toxicity after single course of BCNU.
    Lieberman A; Ruoff M; Estey E; Seidman I; Lieberman I; Wise A
    Am J Med Sci; 1980; 279(1):53-6. PubMed ID: 7369249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Late BCNU lung: a light and ultrastructural study on the delayed effect of BCNU on the lung parenchyma.
    Hasleton PS; O'Driscoll BR; Lynch P; Webster A; Kalra SJ; Gattamaneini HR; Woodcock AA; Poulter LW
    J Pathol; 1991 May; 164(1):31-6. PubMed ID: 2056387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCNU (1,3-bis-(2-chloroethyl)-1-nitrosurea) lung. Drug-induced pulmonary changes.
    Mitsudo SM; Greenwald ES; Banerji B; Koss LG
    Cancer; 1984 Aug; 54(4):751-5. PubMed ID: 6744207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary fibrosis after prolonged therapy with 1,3-bis (2-chloroethyl)-1-nitrosourea.
    Crittenden D; Tranum BL; Haut A
    Chest; 1977 Sep; 72(3):372-3. PubMed ID: 891293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple pulmonary lesions in a patient treated with BCNU (1,3-bis(2-chloroethyl)-1-nitrosourea) for glioblastoma multiforme.
    Bellot PA; Valdiserri RO
    Cancer; 1979 Jan; 43(1):46-50. PubMed ID: 216479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy with BCNU in recurrent glioma: Analysis of clinical outcome and side effects in chemotherapy-naïve patients.
    Jungk C; Chatziaslanidou D; Ahmadi R; Capper D; Bermejo JL; Exner J; von Deimling A; Herold-Mende C; Unterberg A
    BMC Cancer; 2016 Feb; 16():81. PubMed ID: 26865253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary fibrosis following low-dose 1,3-bis (2-chloroethyl)-1-nitrosourea (BCNU) therapy.
    Melato M; Tuveri G
    Cancer; 1980 Mar; 45(6):1311-4. PubMed ID: 7357522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal pulmonary fibrosis following 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) therapy.
    Bailey CC; Marsden HB; Jones PH
    Cancer; 1978 Jul; 42(1):74-6. PubMed ID: 667809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood.
    O'Driscoll BR; Hasleton PS; Taylor PM; Poulter LW; Gattameneni HR; Woodcock AA
    N Engl J Med; 1990 Aug; 323(6):378-82. PubMed ID: 2370889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary toxicity associated with bischloroethylnitrosourea (BCNU).
    Durant JR; Norgard MJ; Murad TM; Bartolucci AA; Langford KH
    Ann Intern Med; 1979 Feb; 90(2):191-4. PubMed ID: 443651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal pneumothorax in "BCNU lung".
    Wilson KS; Brigden ML; Alexander S; Worth A
    Med Pediatr Oncol; 1982; 10(2):195-9. PubMed ID: 7070355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracarotid chemotherapy with 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) in 5% dextrose in water in the treatment of malignant glioma.
    Johnson DW; Parkinson D; Wolpert SM; Kasdon DL; Kwan ES; Laucella M; Anderson ML
    Neurosurgery; 1987 Apr; 20(4):577-83. PubMed ID: 3587550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary toxicity from carmustine (BCNU): a case report.
    Weiss RB; Shah S; Shane SR
    Med Pediatr Oncol; 1979; 6(3):255-9. PubMed ID: 470840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limitations of high dose intra-arterial 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) chemotherapy for malignant gliomas.
    Kapp J; Vance R; Parker JL; Smith RR
    Neurosurgery; 1982 Jun; 10(6 Pt 1):715-9. PubMed ID: 7110545
    [No Abstract]   [Full Text] [Related]  

  • 17. Pulmonary toxicity in long-term administration of BCNU.
    Holoye PY; Jenkins DE; Greenberg SD
    Cancer Treat Rep; 1976 Nov; 60(11):1691-4. PubMed ID: 1021241
    [No Abstract]   [Full Text] [Related]  

  • 18. Early pulmonary toxicity after administration of high-dose BCNU.
    Litam JP; Dail DH; Spitzer G; Vellekoop L; Verma DS; Zander AR; Dicke KA
    Cancer Treat Rep; 1981; 65(1-2):39-44. PubMed ID: 6261949
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatal pulmonary fibrosis associated with BCNU: the relative role of platelet-derived growth factor-B, insulin-like growth factor I, transforming growth factor-beta1 and cyclooxygenase-2.
    Shen YC; Chiu CF; Chow KC; Chen CL; Liaw YC; Yeh SP
    Bone Marrow Transplant; 2004 Oct; 34(7):609-14. PubMed ID: 15286697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapidly progressive, fatal pulmonary fibrosis induced by carmustine.
    Patten GA; Billi JE; Rotman HH
    JAMA; 1980 Aug; 244(7):687-8. PubMed ID: 7392168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.